CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 60,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 500,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 280,000 shares at $0.18 ($50,008)
- 4 Open-market buy Chief Executive Officer bought 1,400,000 shares at $0.18 ($250,040)
- 4 Open-market buy Director bought 280,000 shares at $0.18 ($50,008)
- 4 Open-market buy Director bought 1,400,000 shares at $0.18 ($250,040)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion VP - Finance & CFO acquired 100,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 100,000 shares (option exercise)
- 4 Open-market sale Vice President-Finance & CFO sold 76,000 shares at an average $0.38 ($29,095)
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
Page 21 of 24 · 471 filings